By Steve Mister, President & CEO, Council for Responsible Nutrition04.26.22
Editor’s Note: Views and opinions expressed in guest articles are intended to engage stakeholders and do not necessarily reflect those held by Nutraceuticals World or editorial staff.
This week, Senator Richard Durbin (D-IL) introduced the Dietary Supplement Listing Act of 2022 (S. 4090), which would create a mandatory product listing requirement for dietary supplements. Basically, the legislation would require every marketer of finished product supplements to provide a copy of their labels to FDA as it brings the product to market. Under this legislation, FDA does not get to “approve” or “reject” the product—it must accept the label and post it in a publicly available website so that regulators, retailers, and consumers can see what supplements are in the U.S. marketplace at any given time. CRN has expressed strong support for this proposal.
Unfortunately, some stakeholders have opposed mandatory listing without completely understanding w
FREE SUBSCRIPTION
Continue reading this story and get 24/7 access to Nutraceuticals World for FREE
FREE SUBSCRIPTION
